Back to Search
Start Over
Supplementary Figure Legend from GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death In Vitro and In Vivo
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file, 63KB.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....5c8938a4a8f28166267fb8e475c7ee2d
- Full Text :
- https://doi.org/10.1158/1078-0432.22443515.v1